Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna.

Organisations Organisation Marinomed Biotech AG (VSE: MARI)
  Organisation 2 Link Health (Guangzhou LingSheng Pharma Tech Co., Ltd.)
Products Product Marinosolv® technology platform
  Product 2 business development (state/region)
Index terms Index term Link Health–Marinomed: drug delivery technology, 201901– collab registration + distribution of Marinosolv products in China by Link Health
  Index term 2 Marinomed–EU (govt): credit, 20901–2027 up to €15m EIB credit 2019–2022 repayable 2024–2027
Persons Person Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO)
  Person 2 Prieschl-Grassauer, Eva (Marinomed Biotechnologie GmbH 201307 CSO)

Record changed: 2019-02-03


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Marinomed Biotech AG (VSE: MARI)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top